Am Fam Physician. 2002 Oct 15;66(8):1401-1402.
to the editor: Dr. Mallin's article, “Smoking Cessation: Integration of Behavioral and Drug Therapies,”1 drew helpful attention to the importance of the behavioral aspect of addressing tobacco dependence. It is important to include users of smokeless tobacco, as they often have more difficulty quitting because of the sustained high nicotine levels. The recent national tobacco cessation guideline (surgeon general.gov/tobacco) underlined that physicians must focus not simply on smoking cessation, but also on treatment of tobacco dependence.
Tobacco dependence is a chronic relapsing condition that requires consistent efforts by the patient, physician, and the entire health care system. Physicians can help patients quit tobacco by encouraging them during phone calls regarding test results or scheduling, and by adding a notation to faxed prescription refill requests, such as “If still smoking, encourage to quit.” Pharmacists should also encourage patients to quit tobacco, because tobacco use alters the blood levels of many medications.2
The national guidelines listed bupropion, clonidine, and nortriptyline as pharmacotherapies that reliably increase long-term smoking abstinence rates.3 Nicotine replacement therapy (NRT) often needs to be personalized, with many highly addicted tobacco users needing more than the standard dosages approved by the U.S. Food and Drug Administration (FDA). The Mayo Clinic Nicotine Dependence Center (www.mayoclinic.org/ndc-rst) pioneered the use of high-dose NRT, such as more than one 21-mg nicotine patch per day and combining the nicotine patch with nicotine gum, inhaler, and/or nasal spray. Inhaler users need to be advised to puff for mouth absorption rather than inhale to minimize the cough and sore throat that inhalation can cause. The common rhinitis caused by nasal spray usually resolves over several days. Nicotine lozenges and sublingual tablets are available in Europe and may eventually be available in the United States.
Many patients have access to the Internet and can find great support for quitting tobacco. Some helpful sites include the American Lung Association (www.ffsonline.org); the National Spit Tobacco Education Program (www.nstep.org); Nicotine Anonymous (www.nicotine-anonymous.org); the American Cancer Society (www.cancer.org);www.kickbutt.org;www.tobaccofreekids.org; andwww.quitnet.com. Many states have telephone quit-lines that offer tobacco cessation counseling, quit kits, access to medications, information, and referrals, such as Washington state's 877-270-STOP (877-270-7867). The American Legacy Foundation's Great Start (www.americanlegacy.org/greatstart; 866-66-START [866-667-8278]) is a nationwide service designed for pregnant women trying to quit tobacco.
Worldwide efforts include International Quit&Win 2002 (www.quitandwin.org), which is a contest to encourage tobacco users to quit tobacco for the entire month of May with a $10,000 grand prize drawing; however, only four counties in the United States currently participate. World No Tobacco Day (www.worldnotobaccoday.com) is a similar one day promotion held on May 31.
The American Academy of Family Physicians (AAFP) Stop Smoking Kit, developed by family physicians, contains patient materials, a physician/office staff manual, and chart forms for use in a primary care office.
Dr. Covert-Bowlds received funding for tobacco cessation talks from GlaxoSmithKline.
1. Mallin R. Smoking cessation: integration of behavioral and drug therapies. Am Fam Physician. 2002;65:1107–14.
2. Goldstein MG, Niaura R. Methods to enhance smoking cessation after myocardial infarction. Med Clin North Am. 2000;84:63–80.
3. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating Tobacco Use and Dependence. Quick Reference Guide for Clinicians. Rockville, Md: U.S. Department of Health and Human Services, Public Health Service; 2000.
Send letters to email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
Copyright © 2002 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions